Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 27 (TRIM27) is a 58 kDa intracellular protein encoded by the *TRIM27* gene and belongs to the tripartite motif (TRIM) family of proteins, specifically the C-IV subfamily[1]. It contains a RING finger domain, two B-box domains, a coiled-coil domain, and a PRYSPRY domain, and is classified as a RING-type E3 ubiquitin ligase[1]. TRIM27 is involved in diverse cellular processes such as ubiquitination, regulation of transcription, and signal transduction. Functionally, TRIM27 modulates several key pathways, including PI3K/AKT (by inhibiting PTEN), Wnt/β-catenin (by degrading SIX3), and IL-6/JAK/STAT3 (by recruiting and promoting phosphorylation of JAK1 and STAT3), which contribute to cell proliferation, apoptosis regulation, and immune response modulation[1][3]. TRIM27 plays a crucial role in cancer progression and is often upregulated in various malignancies, promoting proliferation, epithelial-mesenchymal transition, invasion, and metastasis[2][3]. Its function in inflammation, immune signaling, and response to viral infection has also been documented, making it a potential therapeutic target and biomarker in cancer and inflammatory diseases[1][2][3].
Modulation of PI3K/AKT signaling via inhibition of PTEN phosphatase activity. Promotion of Wnt/β-catenin signaling via degradation of SIX3. Promotion of STAT3 phosphorylation and downstream signaling (IL-6/JAK/STAT pathway). Regulation of immune responses by modulating TBK1 degradation and IFN production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 27 (TRIM27).